Overcoming trastuzumab resistance with nordihydroguaiaretic acid?
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Biomedical subjects
Kadri Altundag
Publications and source records attributed to Kadri Altundag.
Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa.
Explore the source record for details and available documents.
Anthracyclines↗
Heparanase activity and bone loss in postmenopausal breast cancer patients.
Explore the source record for details and available documents.
Androstadienes↗
Inactivation of E-cadherin and less sensitivity of lobular breast carcinoma cells to chemotherapy.
Explore the source record for details and available documents.
Breast Neoplasms↗
Hormone receptor status of primary tumor as a prognostic factor in patients with liver metastases from breast cancer treated with transcatheter arterial chemoembolization.
Explore the source record for details and available documents.
Breast Neoplasms↗
Angiotensin 1-7 and risk for breast cancer recurrence.
Explore the source record for details and available documents.
Angiotensin I↗
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a Phase II clinical trial.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Adjuvant chemotherapy in patients 80-89 years of age with non-small cell lung cancer.
Explore the source record for details and available documents.
Age Factors↗
Low incidence of mamographically detected microcalcification in breast cancer patients with lobular histology may be attributed to low levels of osteopontin.
Explore the source record for details and available documents.
Breast Neoplasms↗
Heparin and CXCL12 dimerization.
Explore the source record for details and available documents.
Anticoagulants↗
Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue.
Explore the source record for details and available documents.
Bone Density Conservation Agents↗
Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma.
Explore the source record for details and available documents.
Animals↗
Imatinib may be useful in the management of patients with glioblastoma.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Adjuvant trastuzumab use in high-risk breast cancer patients may prevent development of contralateral estrogen receptor-negative breast tumors.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
Explore the source record for details and available documents.
Antineoplastic Agents, Phytogenic↗
Activation patterns of epidermal growth factor-receptor signaling in glioblastoma multiforme: in regard to Chakravarti et al. (Int J Radiat Oncol Biol Phys 2005;62:318-327).
Explore the source record for details and available documents.
Brain Neoplasms↗
Increased cabbage intake may inhibit metastatic and invasive capacity of breast cancer cells by inhibiting CXCL12(SDF-1 alpha)/CXCR4.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Incidence of plasma cell dyscrasia as a second primary malignancy may be low in postmenopausal breast cancer survivors treated with selective estrogen receptor modulator or aromatase inhibitor.
Explore the source record for details and available documents.
Aromatase Inhibitors↗